October 15, 2015 / 3:26 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Manitowoc, Imprivata, Dexcom, Seagate

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks opened higher on Thursday, after two days of losses, as investors assessed economic data and earnings reports from major banks. The Dow Jones industrial average was up 0.46 percent at 17,002.58, the S&P 500 was up 0.48 percent at 2,003.73 and the Nasdaq Composite was up 0.69 percent at 4,815.931.

** HCA HOLDINGS INC, $71.04, -6.55 pct

** TENET HEALTHCARE CORP, $33.39, -4.71 pct

** COMMUNITY HEALTH SYSTEMS INC, $39.88, -4.32 pct

** UNIVERSAL HEALTH SERVICES INC, $122.94, -2.65 pct

** LIFEPOINT HEALTH INC, $70.28, -4.42 pct

** UNITEDHEALTH GROUP INC, $120.13, -1.59 pct

HCA, the largest for-profit U.S. hospital operator, estimated third-quarter profit that fell short of analysts’ expectation, hurt by higher labor costs and less favorable payer mix.

The weak estimate also weighed on shares of its peers. UnitedHealth, the largest U.S. health insurer, was also down.


The drug developer said its experimental drug reduced severe agitation and aggression in Alzheimer’s patients, citing data from a large study.

** KERYX BIOPHARMACEUTICALS INC, $4.1199, +10.16 pct

The drugmaker said it would reduce expenses by $87-$92 million in 2016. The company also signed a $125 million private placement deal with funds managed by the Baupost Group LLC.

** DEXCOM INC, $80.04, +13.29 pct

The medical device maker estimated third-quarter preliminary revenue of $105 million while analysts expected $97.5 million. The company said preliminary revenue was up 52 percent from year ago. The company is set to post 12th straight quarter of more than 50 percent revenue growth.

** IMPRIVATA INC, $11.24, -35.07 pct

The healthcare IT security company on Wednesday estimated third-quarter revenue below market expectations. The company also sees a bigger-than-expected adjusted loss.

** MANITOWOC CO INC, $14.41, -11.92 pct

The crane maker estimated third-quarter sales below analysts’ expectations, hurt by lower-than-expected tower and crawler crane shipment. “... Cranes segment continued to be negatively impacted by a deteriorating demand environment, particularly in the Middle East and Asia,” Manitowoc said.

** SEAGATE TECHNOLOGY PLC, $41.77, -12.62 pct

The hard disk drive maker estimated first-quarter revenue and gross margin to fall short of forecast. The company said gross margin would be lower than expected due to weak inter-quarter demand for 4TB and 6TB HDD nearline products.

** CITIGROUP INC, $52.03, +2.58 pct

The third biggest U.S. bank by assets reported a 51 percent rise in third-quarter profit as a fall in operating, legal and repositioning costs more than made up for lower revenue.

** GOLDMAN SACHS GROUP INC, $181.26, +0.97 pct

The Wall Street bank reported a sharp drop in profit for the second straight quarter as bond trading revenue fell by a third amid turmoil stemming from concerns about global growth.


The Canadian drugmaker, under fire for price increases of its two heart drugs, said it was subpoenaed by U.S. prosecutors on its pricing, drug distribution and patient assistance programs.

** NETFLIX INC, $101.74, -7.70 pct

The video-streaming service provider reported third-quarter U.S. subscriber additions below its own forecast, blaming a transition to chip-based cards for the miss.

** BRISTOL-MYERS SQUIBB CO, $62.78, +1.13 pct

** FIVE PRIME THERAPEUTICS INC, $26.94, +59.31 pct

Drugmaker Bristol-Myers Squibb said it agreed to exclusively license and collaborate with Five Prime to develop and commercialize Five Prime’s antibody program in the treatment of cancer.

** UNILEVER PLC, $44.79, +3.90 pct

The consumer goods maker reported better-than-expected third-quarter sales, but said sluggish markets globally continued to weigh on its performance.

** NIKE INC, $128.57, +2.17 pct

The world’s largest sportswear maker’s revenue is set to grow faster over the next five years than it had in the previous five. Nike said it expects revenue to increase 63 percent to $50 billion by fiscal 2020, boosted by growth in its e-commerce, women’s and Jordan brand businesses.


The drugmaker said the FDA approved a change in manufacturing specification for Bunavail, allaying concerns about impact to supply of the drug that controls dependence on opioids. The approval permits for the immediate release of Bunavail to wholesalers. (Compiled by Kshitiz Goliya in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below